These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9867077)

  • 1. Potential benefit of inhibitors of advanced glycation end products in the progression of type II diabetes: a study with aminoguanidine in C57/BLKsJ diabetic mice.
    Piercy V; Toseland CD; Turner NC
    Metabolism; 1998 Dec; 47(12):1477-80. PubMed ID: 9867077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aminoguanidine on serum advanced glycation endproducts, urinary albilmin excretion, mesangial expansion, and glomerular basement membrane thickening in Otsuka Long-Evans Tokushima fatty rats.
    Yamauchi A; Takei I; Makita Z; Nakamoto S; Ohashi N; Kiguchi H; Ishii T; Koike T; Saruta T
    Diabetes Res Clin Pract; 1997 Jan; 34(3):127-33. PubMed ID: 9069563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
    Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
    Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model.
    Hammes HP; Strödter D; Weiss A; Bretzel RG; Federlin K; Brownlee M
    Diabetologia; 1995 Jun; 38(6):656-60. PubMed ID: 7672485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoguanidine prolongs survival in azotemic-induced diabetic rats.
    Friedman EA; Distant DA; Fleishhacker JF; Boyd TA; Cartwright K
    Am J Kidney Dis; 1997 Aug; 30(2):253-9. PubMed ID: 9261037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats.
    Chang GJ; Yeh YH; Chen WJ; Ko YS; Pang JS; Lee HY
    J Pharmacol Exp Ther; 2019 Jan; 368(1):66-78. PubMed ID: 30381326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glutathione levels are reduced in Goto-Kakizaki rat retina, but are not influenced by aminoguanidine treatment.
    Agardh CD; Agardh E; Hultberg B; Qian Y; Ostenson CG
    Curr Eye Res; 1998 Mar; 17(3):251-6. PubMed ID: 9543633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous advanced glycation end products in pancreatic islets after short-term carbohydrate intervention in obese, diabetes-prone mice.
    Kehm R; Rückriemen J; Weber D; Deubel S; Grune T; Höhn A
    Nutr Diabetes; 2019 Mar; 9(1):9. PubMed ID: 30858378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.
    Jeyabal PV; Kumar R; Gangula PR; Micci MA; Pasricha PJ
    Neurogastroenterol Motil; 2008 Mar; 20(3):253-61. PubMed ID: 17971026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress.
    Pei Z; Deng Q; Babcock SA; He EY; Ren J; Zhang Y
    Toxicol Lett; 2018 Mar; 284():10-20. PubMed ID: 29174818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of advanced glycation end products by aminoguanidine restores mast cell numbers and reactivity in alloxan-diabetic rats.
    Carvalho VF; Florim LT; de O Barreto E; Torres RC; Batista MM; Amendoeira FC; Cordeiro RS; Martins MA; E Silva PM
    Eur J Pharmacol; 2011 Nov; 669(1-3):143-8. PubMed ID: 21864526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement by aminoguanidine of insulin secretion from pancreatic islets grafted to syngeneic diabetic rats.
    Hiramatsu S; Inoue K; Tajirl Y; Grill V
    Biochem Pharmacol; 2000 Jul; 60(2):263-8. PubMed ID: 10825471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
    Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
    Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice.
    Tamarat R; Silvestre JS; Huijberts M; Benessiano J; Ebrahimian TG; Duriez M; Wautier MP; Wautier JL; Lévy BI
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8555-60. PubMed ID: 12805564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in Streptozotocin-treated diabetic rats.
    Yamabe N; Kang KS; Goto E; Tanaka T; Yokozawa T
    Biol Pharm Bull; 2007 Mar; 30(3):520-6. PubMed ID: 17329849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
    Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.
    Soulis T; Cooper ME; Vranes D; Bucala R; Jerums G
    Kidney Int; 1996 Aug; 50(2):627-34. PubMed ID: 8840295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of advanced glycation end-products and aminoguanidine on TNFalpha production by rat peritoneal macrophages.
    Rashid G; Luzon AA; Korzets Z; Klein O; Zeltzer E; Bernheim J
    Perit Dial Int; 2001; 21(2):122-9. PubMed ID: 11330554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine.
    Li YM; Steffes M; Donnelly T; Liu C; Fuh H; Basgen J; Bucala R; Vlassara H
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3902-7. PubMed ID: 8632987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.
    Wilkinson-Berka JL; Kelly DJ; Koerner SM; Jaworski K; Davis B; Thallas V; Cooper ME
    Diabetes; 2002 Nov; 51(11):3283-9. PubMed ID: 12401720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.